Main Article Content
Purpose: An astonishing amount of work has been put out in recent years to pinpoint biomarkers as possible resources for enhancing psychiatric preventive care, diagnosis, therapeutic response, and therapeutic development. In contrast to those other ailments, psychological illnesses include a diverse range of symptoms that are grouped into diagnostic categories. As a result, persons that have the same psychological disorder have a large deal of therapeutic variation. The above aspect, together with our poor understanding of the neurochemical imbalances driving dissociative ailments, leads to the existing pharmaceutical choices' low effectiveness. In this regard, the discovery of biomarkers in psychology or psychiatry, or any other clinical mental health sciences area is turning out to be crucial for facilitating diagnosis and through the creation of markers that enable the stratification of individuals inside this condition, which may then result in more targeted therapy choices. This evaluation presents a practical description of therapeutic development along with an overview of the idea and several categories of biomarkers to throw light on the subject. Additionally, the developments in this area were compiled and divided into the following groups, including "genetics, transcriptomics, proteomics, metabolomics, and epigenetics".
Objective: The main objective of this paper is to shed some light on the area of neuropsychological disorder and its variations as well as common biomarker assessment methods to detect it. Another core objective of this paper is to rule out "omics" techniques used in the domain of neuropsychology or general psychiatry to detect some complicated and common mental disorders.
Design/Methodology/Approach: This clinical paper is prepared by using secondary data from various official and authentic websites and journal papers. In order to make the paper more accurate and scientific in nature, primary data has also been utilized to build this paper. Expert opinions from neuropsychologists, general psychiatrists, and researchers who are doing research in the domain of neuropsychology have also been taken to guarantee the reliability of the paper.
Findings/Result: Despite the positive outcomes, there have been few biomarker studies, particularly those that focus on the treatment of mental illnesses. This study's outcome makes a comment on the difficulties that will need to be overcome in the possible future in order to generate credible, trustworthy, and widely applicable biomarkers for mental diseases and their intervention. An essential first step towards the construction of more customized therapy is the detection of characteristics that forecast response to therapy since doing so will decrease drug switching based on trial and error and facilitate the development of novel successful medicines.
Originality and Value: A scientific and more comprehensive approach has been taken to provide better information about neuropsychological/general psychiatric disorders and their detection by using histological or any other clinically proven methods. A new stratagem is applied to shed light on the topic of neuropsychological illnesses and their detection by using the biomarker method.
Paper Type: Clinical analysis/interpretive paper
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.